Café

600511

600511

28.380.11%( -0.03 )

Shineway Profit Rises Despite Revenue Slump as TCM Sector Resets

Tip Ranks

Mar 27, 2026 at 04:09 AM

Shineway Profit Rises Despite Revenue Slump as TCM Sector Resets

Source: Tip Ranks The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Related Stocks

SHINEWAY PHARM

HK02877

Hinova

SH688302

SINOPHARM(CNCM LTD)

SH600511

Recommended Readings

Innovative Drug Revenue Share Surpasses 60% for First Time, HENGRUI PHARMA Q1 Revenue Hits 8.14 Billion Yuan, Net Profit…Apr 22, 2026 at 10:30 AM
Official Announcement: US Maintains 50% Metal Tariffs, Imposes 25% Tariffs on Some Finished Products, 100% on Patented D…Apr 2, 2026 at 07:24 PM
Buying Platforms, Selling Pipelines: Deconstructing the Innovation Logic of SINO BIOPHARMMar 27, 2026 at 05:24 AM
The Reality and Illusion of "AI Drug Discovery" XTALPI's TurnaroundMar 26, 2026 at 07:03 AM
Stronger After No Longer "Flying Solo"Mar 25, 2026 at 07:02 AM

Related Stocks

SHINEWAY PHARM

HK02877

Hinova

SH688302

SINOPHARM(CNCM LTD)

SH600511

LongbridgeAI

© 2026 Longbridge｜Terms of Service Privacy Policy